Literature DB >> 6378283

Practical breast carcinoma cell kinetics: review and update.

J S Meyer, R W McDivitt, K R Stone, M U Prey, W C Bauer.   

Abstract

The S-phase fraction (SP) measured by flow cytometry of DNA and the thymidine labeling index (TLI) measured autoradiographically indicate the proportion of carcinoma cells currently synthesizing DNA and reflect the rate of proliferation. The TLI and SPF are lognormally distributed. The median TLI performed to maximize precursor uptake is near 5% (5 labeled carcinoma cells per 100) the mean near 7%, and the range from less than 1% to near 40%. Corresponding values for the SPF measured by DNA flow cytometry are slightly higher when appropriate measures are taken to reduce background debris counts and other artefacts. Residual elevation of SPF above TLI may result from S-phase arrested cells. Flow cytometric histograms show that clearly aneuploid cell lines exist in 50-80% of primary breast carcinomas. Aneuploid breast carcinomas have higher mean TLI than diploid breast carcinomas, and therefore proliferate more rapidly. They also more frequently lack estrogen receptor (ER). Carcinomas with minimal nuclear anaplasia, particularly those of tubular, mucinous, infiltrating lobular and adenocystic types have low TLI and SPF, whereas carcinomas with highly anaplastic nuclei, including medullary carcinomas, have high TLI and SPF. TLI and SPF correlate inversely with ER and PgR content, have no relationship to axillary lymph nodal status, and have a weak positive correlation with tumor size and a weak negative correlation with age. High TLI predicts a high risk of early relapse after primary therapy for both node-negative and node-positive carcinomas. Carcinomas that produce brain metastases have particularly high TLI. Current evidence suggests that high SPF and aneuploidy may prove to have prognostic significance like TLI.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378283     DOI: 10.1007/bf01806389

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  55 in total

1.  Flow cytometry.

Authors:  R C Braylan
Journal:  Arch Pathol Lab Med       Date:  1983-01       Impact factor: 5.534

2.  Cytophotometric measurement of the cellular DNA content of [3H]thymidine-labelled spheroids. Demonstration that some non-labelled cells have S and G2 DNA content.

Authors:  D C Allison; J M Yuhas; P F Ridolpho; S L Anderson; T S Johnson
Journal:  Cell Tissue Kinet       Date:  1983-05

3.  Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.

Authors:  J S Meyer; B R Rao; S C Stevens; W L White
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

4.  Cell proliferation and its relationship to clinical features and relapse in breast cancers.

Authors:  C Gentili; O Sanfilippo; R Silvestrini
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

5.  Nuclear feulgen DNA content and nuclear size in human breast carcinoma.

Authors:  S D Fosså; P F Marton; O S Knudsen; O Kaalhus; O Børmer; S Vaage
Journal:  Hum Pathol       Date:  1982-07       Impact factor: 3.466

6.  The use of trout erythrocytes and human lymphocytes for standardization in flow cytometry.

Authors:  A Jakobsen
Journal:  Cytometry       Date:  1983-09

7.  The influence of age on the DNA ploidy levels of breast tumours.

Authors:  I W Taylor; E A Musgrove; M L Friedlander; M S Foo; D W Hedley
Journal:  Eur J Cancer Clin Oncol       Date:  1983-05

8.  In vitro labeling of solid tissues with tritiated thymidine for autoradiographic detection of S-phase nuclei.

Authors:  J S Meyer; R E Connor
Journal:  Stain Technol       Date:  1977-07

9.  Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer.

Authors:  T E Kute; H B Muss; D Anderson; K Crumb; B Miller; D Burns; L A Dube
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

10.  Effect of 17 beta-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice.

Authors:  N Brünner; M Spang-Thomsen; L Vindeløv; A Nielsen
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

View more
  22 in total

1.  Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors.

Authors:  H Olsson; H Jernström; P Alm; H Kreipe; C Ingvar; P E Jönsson; S Rydén
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Apocrine carcinoma of the breast--a case report.

Authors:  A Tsuchiya; Y Rokkaku; M Nihei; T Nomizu; R Abe
Journal:  Jpn J Surg       Date:  1988-11

3.  Cell dissociation techniques in human breast cancer--variations in tumor cell viability and DNA ploidy.

Authors:  B M Ljung; B Mayall; C Lottich; C Boyer; S S Sylvester; G S Leight; H F Siegler; H S Smith
Journal:  Breast Cancer Res Treat       Date:  1989-03       Impact factor: 4.872

4.  Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.

Authors:  S B Ewers; R Attewell; B Baldetorp; A Borg; E Långström; D Killander
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

5.  Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial.

Authors:  T Hatschek; J Carstensen; G Fagerberg; O Stål; O Gröntoft; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

6.  Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.

Authors:  T E Kute; H B Muss; M Hopkins; R Marshall; D Case; L Kammire
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Proliferative and secretory activity in the pregnant and lactating human breast.

Authors:  S Battersby; T J Anderson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

8.  A general native-state method for determination of proliferation capacity of human normal and tumor tissues in vitro.

Authors:  R M Hoffman; K M Connors; A Z Meerson-Monosov; H Herrera; J H Price
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  The DNA labelling index: a prognostic factor in node-negative breast cancer.

Authors:  M Héry; J Gioanni; C M Lalanne; M Namer; A Courdi
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

10.  Intensive short-term chemotherapy in patients with advanced breast cancer.

Authors:  H E Wander; G A Nagel; H Luig; D Emrich
Journal:  Klin Wochenschr       Date:  1987-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.